PGEN Stock Analysis: Buy, Sell, or Hold?
PGEN - Precigen, Inc. Common Stock
$6.61
0.34 (5.42%)
▲
5d:
+21.96%
30d:
+17.2%
90d:
+62.01%
HOLD
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 6.4/10
Get Alerted When PGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: PGEN is 12.4% above its trading range ($5.88). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: PGEN is 12.4% above its trading range ($5.88). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGEN is currently trading at $6.61, which is considered extended relative to its 30-day fair value range of $5.14 to $5.88. From a valuation perspective, the stock is trading at a discount (Forward PE: 33.0) compared to its historical average (43.1). Remarkably, the market is currently pricing in an annual earnings decline of 8.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PGEN is in a strong uptrend. The price is approaching resistance at $6.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: PGEN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.50 (+89.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PGEN is in a strong uptrend. The price is approaching resistance at $6.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: PGEN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.50 (+89.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.14 -
$5.88
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
PGEN is technically overbought (RSI 74). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- BULLISH: Trading 89.1% below Wall St target ($12.50)
Trading Range Analysis
30-Day Trading Range
$5.14 -
$5.88
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.11
Resistance Level
$6.70
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
33.05
Wall Street Target
$12.50
(+89.1%)
Revenue Growth (YoY)
1633.9%
Valuation Discount vs History
-8.5% cheaper
PE vs Historical
33.1 vs 43.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.5%
(market-implied from PE analysis)
1-Year Target
$6.05
(-9%)
2-Year Target
$5.53
(-16%)
3-Year Target
$5.06
(-23%)
3-Yr Target (if PE normalizes)
(PE: 33→43)
$6.60
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 33.0 to 43.1
Stabilization Target:
$8.62
(+30.4%)
PE Expansion Potential:
+30.4%
Share & Embed Analysis
Last updated: August 04, 2026 6:28 AM ET
Data refreshes hourly during market hours. Next update: 7:28 AM
Data refreshes hourly during market hours. Next update: 7:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Randal J Kirk
SELL
4772781 shares
2026-03-30
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
Advanced PGEN Option Strategies
Professional options setups generated by AI based on today's PGEN price and gamma walls.
